INDEMNIFICATION AGREEMENTIndemnification Agreement • October 2nd, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ______________, 2020 between Foghorn Therapeutics Inc., a Delaware corporation (the “Company”), and ___________________ (“Indemnitee”).
July 11th, 2019 Sam Agresta, M.D. Dear Sam,Foghorn Therapeutics Inc. • October 2nd, 2020 • Pharmaceutical preparations
On behalf of Foghorn Therapeutics (the “Company”), I am delighted to offer you employment with the Company. This offer letter (the “Offer Letter”) and the accompanying documents and agreements summarize and set forth important terms about your employment with the Company.
Re: Employment Offer LetterFoghorn Therapeutics Inc. • October 2nd, 2020 • Pharmaceutical preparations
On behalf of Foghorn Therapeutics, Inc. (the “Company”), I am delighted to offer you employment with the Company. This offer letter (the “Offer Letter”) and the accompanying documents and agreements summarize and set forth important terms about your employment with the Company.
RESEARCH COLLABORATION AND EXCLUSIVE LICENSE AGREEMENT by and between FOGHORN THERAPEUTICS INC. and MERCK SHARP & DOHME CORP.Research Collaboration and Exclusive License Agreement • October 2nd, 2020 • Foghorn Therapeutics Inc. • Pharmaceutical preparations • New York
This agreement (this “Agreement”) is effective as of July 2, 2020, (the “Effective Date”) and is entered into by and between Foghorn Therapeutics Inc., a corporation organized and existing under the laws of Delaware, having an address at 100 Binney Street, Suite 610, Cambridge, MA 02142 (“Company”) and Merck Sharp & Dohme Corp., a corporation organized and existing under the laws of New Jersey with its principal business office located at One Merck Drive, Whitehouse Station, NJ 08889 (“Merck”).
